Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 7/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.40 |
| ▸ | CRHBP | P24387 | 1/20 | 0.40 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 2/20 | 0.39 |
| ▸ | CES1 | P23141 | 2/20 | 0.39 |
| ▸ | KLK7 | P49862 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9764589 | 0.81 | HCAR2 (0.65) | HCAR2ALDH1A1LMNACYP2D6 | |
| SCHEMBL9163949 | 0.79 | CES1 (0.50) | TSHRCNR1CRHBPCRHR2ALDH1A1 | |
| SCHEMBL7441943 | 0.78 | NPSR1 (0.45) | TSHRCNR1CRHBPCRHR2ALDH1A1 | |
| SCHEMBL2487162 | 0.77 | HCAR2 (0.59) | HCAR2ALDH1A1LMNACYP2D6CYP2C19 | |
| SCHEMBL7599647 | 0.77 | KMT2A (0.51) | TSHRCRHBPCRHR2ALDH1A1LMNA | |
| SCHEMBL28803484 | 0.74 | HCAR2 (0.69) | HCAR2CRHBPCRHR2ALDH1A1CYP2D6 | |
| SCHEMBL27534212 | 0.74 | HCAR2 (0.69) | HCAR2CRHBPCRHR2ALDH1A1CYP2D6 | |
| SCHEMBL27722749 | 0.73 | HCAR2 (0.67) | HCAR2CRHBPCRHR2ALDH1A1CYP2D6 | |
| SCHEMBL11095898 | 0.72 | CNR2 (0.44) | TSHRCNR1CRHBPCRHR2ALDH1A1 | |
| SCHEMBL3482646 | 0.72 | HCAR2 (0.61) | HCAR2TSHRALDH1A1LMNACYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | HCAR2 3143/4885TSHR 3581/4885CNR1 1021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.